Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Jiangsu Bioperfectus Technologies Co Ltd
Additional Paid In Capital
Jiangsu Bioperfectus Technologies Co Ltd
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
Additional Paid In Capital
¥806.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Additional Paid In Capital
¥2.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Additional Paid In Capital
¥2.7B
|
CAGR 3-Years
43%
|
CAGR 5-Years
20%
|
CAGR 10-Years
16%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Additional Paid In Capital
¥4.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Additional Paid In Capital
¥4.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Additional Paid In Capital
¥1.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Bioperfectus Technologies Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
806.6m
CNY
Based on the financial report for Dec 31, 2023, Jiangsu Bioperfectus Technologies Co Ltd's Additional Paid In Capital amounts to 806.6m CNY.
What is Jiangsu Bioperfectus Technologies Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
31%
Over the last year, the Additional Paid In Capital growth was 0%.